Neural Bases of the Check Process
Check
2 other identifiers
interventional
51
1 country
1
Brief Summary
Effective exploration of the environment, check for information to improve one's own performance, are fundamental abilities of human cognition. These abilities are dependent on the process of cognitive control. However, they are clearly impaired and uncontrollable in certain behavioral disorders such as obsessive-compulsive disorder (OCD). Compulsive checks of these patients, spontaneously associated with a feeling of intense uncertainty, suggest disturbances of evaluative and metacognitive functions. However, no biological observations have yet been able to feed these hypotheses. The evaluation of decisions and actions involves the middle cingulate cortex (MCC) (which belongs to a cortico-subcortical network structurally and functionally altered in OCD patients). Cingulotomy has long been used as a therapy in severe OCD, with However, the precise part of the cingulate cortex that contributes to check (and its pathological forms) remains to be discovered. The purpose of this research campaign is to determine, through functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) in healthy human subjects:
- 1.the location and role of the MCC region involved in normal check decision processes,
- 2.determine the identity of the entire network involved
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy-volunteers
Started Nov 2018
Typical duration for not_applicable healthy-volunteers
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 7, 2018
CompletedFirst Posted
Study publicly available on registry
March 30, 2018
CompletedStudy Start
First participant enrolled
November 23, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 16, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 16, 2020
CompletedDecember 29, 2025
December 1, 2025
1.1 years
March 7, 2018
December 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Measuring changes in brain activity in regions of interest when performing cognitive tasks.
Behavior: Measurement of reaction times of correct answer during cognitive task. fMRI and EEG: Brain activity signal,
through study completion, an average of 3 years
Measuring changes in brain activity in regions of interest when performing cognitive tasks.
Behavior: Measurement of % of correct answer during cognitive task.
through study completion, an average of 3 years
Measuring changes in brain activity in regions of interest when performing cognitive tasks.
\- Measurement of the amplitude of the BOLD signal change in MRI according to the different cognitive tasks in the different regions of interest. Measurement of resting GABA and Glutamate concentrations in the different regions of interest. Measurement of the amplitude of the change of the electrical signal in EEG according to the different cognitive tasks in the different regions of interest.
through study completion, an average of 3 years
Secondary Outcomes (2)
Calculation of the correlations in the regions of interest of the individual values of the Blood Oxygen Level Dependent (BOLD) signal with the data of the concentration of Acide γ-aminobutyrique (GABA)
through study completion, an average of 3 years
Calculation of the correlations in the regions of interest of the individual values of the Blood Oxygen Level Dependent (BOLD) signal with the data of the amplitude of the electrical signal (EEG)
through study completion, an average of 3 years
Study Arms (1)
fMRI and EEG study
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- adults age range 20-45 years
- being able to provide a written consent form
- having a social insurance
- have a normal vision (with or without corrections)
- Right-handed
You may not qualify if:
- Subjects with MRI contraindications (e.g. pacemaker, claustrophobia, metal in the body, etc…).
- Pregnant subjects
- Subjects with neurological history
- Subjects must be willing to be advise in case of discovery of brain abnormality.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Inserm U1208
Bron, France
Related Publications (1)
Stoll FM, Fontanier V, Procyk E. Specific frontal neural dynamics contribute to decisions to check. Nat Commun. 2016 Jun 20;7:11990. doi: 10.1038/ncomms11990.
PMID: 27319361RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Emmanuel Procyk
INSERM U1208
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2018
First Posted
March 30, 2018
Study Start
November 23, 2018
Primary Completion
January 16, 2020
Study Completion
January 16, 2020
Last Updated
December 29, 2025
Record last verified: 2025-12